➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Merck
Mallinckrodt
Baxter
McKinsey

Last Updated: August 8, 2020

DrugPatentWatch Database Preview

FENOFIBRATE (MICRONIZED) Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Fenofibrate (micronized), and what generic alternatives are available?

Fenofibrate (micronized) is a drug marketed by Ajanta Pharma Ltd, Ani Pharms Inc, Apotex, Austarpharma, Dr Reddys Labs Sa, Glenmark Pharms Ltd, Impax Labs, Invagen Pharms, Mylan Pharms Inc, Novast Labs, Rhodes Pharms, and Torrent. and is included in thirteen NDAs.

The generic ingredient in FENOFIBRATE (MICRONIZED) is fenofibrate. There are forty-two drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the fenofibrate profile page.

US ANDA Litigation and Generic Entry Outlook for Fenofibrate (micronized)

A generic version of FENOFIBRATE (MICRONIZED) was approved as fenofibrate by RHODES PHARMS on May 13th, 2005.

  Start Trial

Drug patent expirations by year for FENOFIBRATE (MICRONIZED)
Recent Clinical Trials for FENOFIBRATE (MICRONIZED)

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Beijing Chao Yang HospitalPhase 4
Hanlim Pharm. Co., Ltd.Phase 1
University of IoanninaPhase 4

See all FENOFIBRATE (MICRONIZED) clinical trials

Pharmacology for FENOFIBRATE (MICRONIZED)

US Patents and Regulatory Information for FENOFIBRATE (MICRONIZED)

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Rhodes Pharms FENOFIBRATE (MICRONIZED) fenofibrate CAPSULE;ORAL 075753-002 Apr 9, 2002 AB RX No No   Start Trial   Start Trial   Start Trial
Novast Labs FENOFIBRATE (MICRONIZED) fenofibrate CAPSULE;ORAL 207564-001 Apr 19, 2019 DISCN No No   Start Trial   Start Trial   Start Trial
Rhodes Pharms FENOFIBRATE (MICRONIZED) fenofibrate CAPSULE;ORAL 075753-003 Apr 9, 2002 AB RX No No   Start Trial   Start Trial   Start Trial
Novast Labs FENOFIBRATE (MICRONIZED) fenofibrate CAPSULE;ORAL 207564-002 Apr 19, 2019 DISCN No No   Start Trial   Start Trial   Start Trial
Ajanta Pharma Ltd FENOFIBRATE (MICRONIZED) fenofibrate CAPSULE;ORAL 210705-001 Sep 10, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Moodys
Mallinckrodt
Medtronic
Boehringer Ingelheim
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.